EMCC European Monitoring Centre on Change



Geographic Location

Country: Poland


Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
Number Employed: 4500

Employment Effects

Announcement Date: 02-10-2020
Planned Job Reductions min: 250
Type of Restructuring: Internal restructuring
Employment Effect Start: 02-10-2020
Foreseen End Date: 31-12-2020

Additional Information

Polish pharmaceutical company Polpharma announced that it will cut about 250 jobs throughout a collective dismissal programme at its units across Poland by the end of 2020. The restructuring programme will affect mainly office staff, and the conditions of the programme will be negotiated with the employees’ representatives. The job cuts are related to the COVID-19 pandemic.

Polpharma was founded as a state-owned company in 1935; it was privatized in 2000. Currently, Polpharma is a leading company on the Polish pharmaceutical market and one of the major drug manufacturers in the region of CEE, Central Asia and the Caucasus. The company employs 4,500 people at five production facilities across Poland.